PSMB1 | Proteasome (prosome, macropain) subunit, beta type, 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
PSMB10 | Proteasome (prosome, macropain) subunit, beta type, 10 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
PSMB2 | Proteasome (prosome, macropain) subunit, beta type, 2 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
PSMB5 | Proteasome (prosome, macropain) subunit, beta type, 5 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
PSMB9 | Proteasome (prosome, macropain) subunit, beta type, 9 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
RET | Ret proto-oncogene | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
RFK | Riboflavin kinase | Enzymes FDA approved drug targets
| | | | | Expressed in all |
RRM1 | Ribonucleotide reductase M1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
RRM2 | Ribonucleotide reductase M2 | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
RRM2B | Ribonucleotide reductase M2 B (TP53 inducible) | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
SHMT1 | Serine hydroxymethyltransferase 1 (soluble) | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
SMOX | Spermine oxidase | Enzymes FDA approved drug targets
| | | | | Expressed in all |
SMS | Spermine synthase | Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SRC | V-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | Cancer-related genes Cytoskeleton related proteins Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Mixed |
TBXAS1 | Thromboxane A synthase 1 (platelet) | Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Mixed |
TOP1 | Topoisomerase (DNA) I | Cancer-related genes Disease related genes Enzymes FDA approved drug targets
| | | | | Expressed in all |
TOP1MT | Topoisomerase (DNA) I, mitochondrial | Enzymes FDA approved drug targets Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
TOP2A | Topoisomerase (DNA) II alpha 170kDa | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enhanced |
TOP2B | Topoisomerase (DNA) II beta 180kDa | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
TXNRD1 | Thioredoxin reductase 1 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
YES1 | V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |